UPMC Hillman Cancer Center

CCSG Acknowledgement

Required CCSG Acknowledgement

The NCI requires that publications acknowledge the Hillman CCSG support, and they are tracking compliance. If a Hillman CCSG-supported Shared Resource provided data used in your publication, please include the following statement in the acknowledgment section of your publication(s):

"This project used the Hillman [insert name(s) of shared resource(s)] that [is/are] supported in part by award P30CA047904."

Shared Resource Directors: Please make sure to include this statement on all of your order forms, contracts, etc. as a reminder to your users to acknowledge the Hillman CCSG support.

Preclinical Imaging

Preclinical imaging of rodent models of cancer has proven highly valuable for elucidating cancer biology, determining early on whether a particular therapy is effective, and for translating molecular imaging modalities, agents and applications into clinical practice. At UPMC Hillman Cancer Center, small animal optical, ultrasound, MR and PET-CT imaging instrumentation reside in one location inside the Animal Facility barrier, enabling investigators to longitudinally image the same mice with multiple modalities. The experts at the IVIF help investigators design imaging studies, whether via single or multiple modalities, that will best address their scientific questions. Assistance with contrast agent development in the areas of optical, MR and PET imaging is also available.

MRI PET-CT Optical Ultrasound